Skip to main content
. 2018 Jul 31;58(11):1468–1478. doi: 10.1002/jcph.1274

Figure 1.

Figure 1

Goodness‐of‐fit plots of the final covariate population pharmacokinetic model (upper, daclatasvir; lower, asunaprevir).